Mark Jara leads the Samples Platform at Medvantx, where he is responsible for integrating and expanding the capabilities of RxS via acquisition, the sample management company he co-founded. With over 25 years in pharmaceutical commercialization and compliance, Mark brings deep expertise across eSampling, field-rep, direct-to-practitioner, and hospital-based programs. His leadership strengthens Medvantx’s ability to deliver end-to-end solutions that connect healthcare providers and patients through a unified patient access ecosystem. He was named to the PharmaVOICE 100 in 2018 for his leadership in advancing access and digital transformation. Mark also served as a board member and partner to the PDMA Sharing Alliance, where he spoke annually on compliance and technology trends shaping the future of sample accountability. He holds a BA in Information Systems from Rutgers/NJIT and an MS in Management from Stevens Institute of Technology. Mark is a committed advocate for Alzheimer’s awareness and research. Inspired by personal family experience, he participates annually in the Walk to End Alzheimer’s and supports efforts that promote early intervention, patient support, and caregiver